Clinical Trial Update: Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 safety study of sildenafil in premature infants with severe bronchopulmonary dysplasia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia of Newborn

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Christoph Hornik | Conditions: Bronchopulmonary Dysplasia of Newborn | Phase 2 | Status: COMPLETED | Results posted: 2026-01-26